Novo Nordisk Pharmaceutical Industries, LP

Safety Insights for Novo Nordisk Pharmaceutical Industries, LP

Novo Nordisk Pharmaceutical Industries, LP operates an establishment with approximately 644 full-time equivalent workers in CLAYTON, NC, classified under the Anesthetic preparations manufacturing industry (NAICS 325412). Across 6 years of mandatory OSHA Injury Tracking Application (ITA) reporting, this employer has accumulated 39 recordable injuries, 6 occupational illnesses, and 0 workplace fatalities. The average Total Case Rate (TCR) of 1.3 injuries per 100 full-time workers per year provides the anchor metric for the A letter grade (Excellent Safety Record).

Benchmarked against the Bureau of Labor Statistics industry average of 3.3 for Anesthetic preparations manufacturing, Novo Nordisk Pharmaceutical Industries, LP's workforce experiences 38% of the typical injury burden. This ratio matters because TCR already normalizes for hours worked — a 200,000-hour exposure base equals roughly 100 full-time workers — so establishments with very different headcounts can be compared directly. A TCR below the benchmark signals that controls, training, or automation may be outperforming peers.

Multi-year trend analysis is the single most reliable signal here: a one-year spike could reflect a single severe event, whereas sustained elevation across 6 reporting cycles points to systemic hazard exposure. Readers evaluating Novo Nordisk Pharmaceutical Industries, LP as an employer, contractor, investment, or regulatory target should examine the yearly DART rate (days away, restricted, or transferred), the fatality count of 0, and any year-over-year deterioration shown in the table below. All figures come directly from employer-submitted OSHA Form 300A summaries — there is no modeling, estimation, or third-party adjustment layered on top of the government data.